Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 20, 2020

SELL
$268.85 - $341.04 $1,881 - $2,387
-7 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$220.06 - $304.07 $7,041 - $9,730
-32 Reduced 82.05%
7 $2,000
Q4 2019

Feb 10, 2020

BUY
$220.06 - $304.07 $8,582 - $11,858
39 New
39 $2,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Firestone Capital Management Portfolio

Follow Firestone Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Firestone Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Firestone Capital Management with notifications on news.